Beta Drugs shares jumped 14% after Q2 FY27 PAT rose 52% YoY, supported by strong H1 performance and FY27 revenue guidance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results